The clinical utility of a near patient care rapid microarray-based diagnostic test for influenza and respiratory syncytial virus infections in the pediatric setting

Diagnostic Microbiology and Infectious Disease

Volumn 78, Issue 4, 2014, Pages 363-367

  Nakao, Akihiro ^a   Hisata, Ken ^a   Matsunaga, Nobuaki ^a   Fujimori, Makoto ^a   Yoshikawa, Naomi ^a   Komatsu, Mitsutaka ^a   Kikuchi, Ken ^a   Takahashi, Hiroshi ^b   Shimizu, Toshiaki ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b East West Diagnostics/Theranostics   (United States)

Author keywords

Influenza; Microarray: Immunochromatography; Near patient care test; Pediatrics; Rapid antigen test; Respiratory syncytial virus

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE COURSE; FEMALE; HUMAN; INFANT; INFLUENZA; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MOLECULAR DIAGNOSIS; PREDICTIVE VALUE; PRIORITY JOURNAL; RAPID IMMUNOCHROMATOGRAPHIC ANTIGEN TEST; RESPIRATORY SYNCYTIAL VIRUS INFECTION; SENSITIVITY AND SPECIFICITY; VERIGENE RESPIRATORY VIRUS PLUS NUCLEIC ACID TEST;

INFLUENZA; MICROARRAY: IMMUNOCHROMATOGRAPHY; NEAR PATIENT CARE TEST; PEDIATRICS; RAPID ANTIGEN TEST; RESPIRATORY SYNCYTIAL VIRUS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DIAGNOSTIC TESTS, ROUTINE; FEMALE; HUMANS; IMMUNOCHROMATOGRAPHY; INFANT; INFLUENZA, HUMAN; MALE; MICROARRAY ANALYSIS; MOLECULAR DIAGNOSTIC TECHNIQUES; ORTHOMYXOVIRIDAE; POINT-OF-CARE SYSTEMS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; SENSITIVITY AND SPECIFICITY;

EID: 84895883750     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2013.11.005     Document Type: Article

References (35)

1. Alby K., Popowitch E.B., Miller M.B. Comparative evaluation of the Nanosphere Verigene RV+ assay and the Simplexa Flu A/B & RSV kit for detection of influenza and respiratory syncytial viruses. J Clin Microbiol 2013, 51:352-353.
2. Bishop J.F., Murnane M.P., Owen R. Australia's winter with the 2009 pandemic infiuenza A(H1N1) virus. N Engl J Med 2009, 361:2591-2594.
3. Boku S., Naito T., Murai K., Tanei M., Inui A., Nisimura H., et al. Near point-of-care administration by the attending physician of the rapid influenza antigen detection immunochromatography test and the fully automated respiratory virus nucleic acid test: contribution to patient management. Diagn Microbiol Infect Dis 2013, 76:445-449.
4. Centers for Disease Control and Prevention (CDC) Outbreak of swine-origin influenza A (H1N1) virus infection - Mexico, March-April 2009. MMWR Morb Mortal Wkly Rep 2009, 58:467-470.
5. Centers for Disease Control and Prevention (CDC) Guidance for Clinicians on the Use of Rapid Influenza Diagnostic Tests Retrieved December 15, 2012, from. http://www.cdc.gov/flu/professionals/diagnosis/clinician_guidance_ridt.htm.
6. Domínguez-Cherit G., Lapinsky S.E., Macias A.E., Pinto R., Espinosa-Perez L., de la Torre A., et al. Critically ill patients with 2009 influenza A(H1N1) in Mexico. JAMA 2009, 302:1880-1887.
7. Faix D.J., Sherman S.S., Waterman S.H. Rapid-test sensitivity for novel swine-origin influenza A(H1N1) virus in humans. N Engl J Med 2009, 361:728-729.
8. Gao R., Cao B., Hu Y., Feng Z., Wang D., Hu W., et al. Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med 2013, 368:1888-1897.
9. Glezen W.P. Feigin and Cherry's textbook of pediatric infectious diseases 2009, 2395-2413. Saunders, Philadelphia, PA, USA. 6th ed.
10. Gubareva L.V. Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors. Virus Res 2004, 103:199-203.
11. Hall C.B., Walsh E.E. Feigin and Cherry's textbook of pediatric infectious diseases 2009, 2462-2487. Saunders, Philadelphia, PA, USA. 6th ed.
12. Hall C.B., Weinberg G.A., Iwane M.K., Blumkin A.K., Edwards K.M., Staat M.A., et al. The burden of respiratory syncytial virus infection in young children. N Eng J Med 2009, 360:588-598.
13. Itoh Y., Shinya K., Kiso M., Watanabe T., Sakoda Y., Hatta M., et al. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 2009, 460:1021-1025.
14. Jannetto P.J., Buchan B.W., Vaughan K.A., Ledford J.S., Anderson D.K., Henley D.C., et al. Real-time detection of influenza A, influenza b, and respiratory syncytial virus A and B in respiratory specimens by use of nanoparticle probes. J Clin Microbiol 2010, 48:3997-4002.
15. Kawai N., Ikematsu H., Tanaka O., Matsuura S., Maeda T., Yamauchi S., et al. Comparison of the clinical symptoms and the effectiveness of neuraminidase inhibitors for patients with pandemic influenza H1N1 2009 or seasonal H1N1 influenza in the 2007-2008 and 2008-2009 seasons. J Infect Chemother 2011, 17:375-381.
16. Keitel K., Wagner N., Lacroix L., Manzano S., Gervaix A. Performance characteristics of a rapid immunochromatographic assay for detection of pandemic influenza A (H1N1) virus in children. Eur J Pediatr 2011, 170:511-517.
17. Kumar S., Henrickson K.J. Update on influenza diagnostics: Lessons from the novel H1N1 influenza A pandemic. Clin Microbiol Rev 2012, 25:344-361.
18. Loeffelholz M.J., Pong D.L., Pyles R.B., Xiong Y., Miller A.L., Bufton K.K., et al. Comparison of the FilmArray respiratory panel and Prodesse real-time PCR assays for detection of respiratory pathogens. J Clin Microbiol 2012, 49:4083-4088.
19. Lucas P.M., Morgan O.W., Gibbons T.F., Guerrero A.C., Maupin G.M., Butler J.L., et al. Diagnosis of 2009 pandemic influenza A (pH1N1) and seasonal influenza using rapid influenza antigen tests, San Antonio, Texas, April-June 2009. Clin Infect Dis 2011, 52:S116-S122.
20. Mahony J.B. Detection of respiratory viruses by molecular methods. Clin Microbiol Rev 2008, 21:716-747.
21. Maines T.R., Jayaraman A., Belser J.A., Wadford D.A., Pappas C., Zeng H., et al. Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science 2009, 325:484-487.
22. Motulsky H. Intuitive biostatistics 1995, Oxford University Press, New York.
23. Munster V.J., de Wit E., van den Brand J.M., Herfst S., Schrauwen E.J., Bestebroer T.M., et al. Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. Science 2009, 325:481-483.
24. Novak-Weekley S.M., Marlowe E.M., Poulter M., Dwyer D., Speers D., Rawlinson W., et al. Evaluation of the Cepheid Xpert Flu Assay for rapid identification and differentiation of influenza A, influenza A 2009 H1N1, and influenza B viruses. J Clin Microbiol 2012, 50:1704-1710.
25. Numazaki Y., Oshima T., Ohmi A., Tanaka A., Oizumi Y., Komatsu S., et al. A microplate method for isolation of viruses from infants and children with acute respiratory infections. Microbiol Immunol 1987, 31:1085-1095.
26. Silvennoinen H., Peltola V., Lehtinen P., Vainionpää R., Heikkinen T. Clinical presentation of influenza in unselected children treated as outpatients. Pediatr Infect Dis J 2009, 28:372-375.
27. Simon A., Ammann R.A., Wilkesmann A., Eis-Hübinger A.M., Schildgen O., Weimann E., et al. Respiratory syncytial virus infection in 406 hospitalized premature infants: results from a prospective German multicentre database. Eur J Pediatr 2007, 166:1273-1283.
28. Sommer C., Resch B., Simões E.A. Risk factors for severe respiratory syncytial virus lower respiratory tract infection. Open Microbiol J 2011, 5:144-154.
29. Storhoff J.J., Marla S.S., Bao P., Hagenow S., Mehta H., Lucas A., et al. Gold nanoparticle based detection of genomic DNA targets on microarrays using a novel optical detection system. Biosens Bioelectron 2004, 19:875-883.
30. Sugaya N., Ohashi Y. Long-acting neuraminidase inhibitor laninamivir octanoate (CS-8958) versus oseltamivir as treatment for children with influenza virus infection. Antimicrob Agents Chemother 2010, 54:2575-2582.
31. U.S.Food and Drug Administration Guidance for Industry and FDA Staff - establishing the performance characteristics of in vitro diagnostic devices for the detection or detection and differentiation of influenza viruses. 2011 Retrieved December 15, 2012, from. http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm079171.htm.
32. Vasoo S., Stevens J., Singh K. Rapid antigen tests for diagnosis of pandemic (swine) influenza A/H1N1. Clin Infect Dis 2009, 49:1090-1093.
33. Watanabe A., Chang S.C., Kim M.J., Chu D.W., Ohashi Y. Long-acting neuraminidase inhibitor laninamivir octanoate versus oseltamivir for treatment of influenza: a double-blind, randomized, noninferiority clinical trial. Clin Infect Dis 2010, 51:1167-1175.
34. Welch D.F., Ginocchio C.C. Role of rapid immunochromatographic antigen testing in diagnosis of influenza A virus 2009 H1N1 infection. J Clin Microbiol 2010, 48:22-25.
35. World Health Organization (WHO) WHO guidelines for pharmacological management of pandemic influenza A(H1N1) 2009 and other influenza viruses, February 2010 Retrieved December 15, 2012, from. http://www.who.int/csr/resources/publications/swineflu/h1n1_use_antivirals_20090820/en/.